Name: Platform Trial Designs in Drug Development: Umbrella Trials and Basket Trials (en Inglés)
Price: 111590.00 CLP
Availability: InStock
Author: Antonijevic, Zoran ; Beckman, Robert A.
ISBN: 9781138052451

portada Platform Trial Designs in Drug Development: Umbrella Trials and Basket Trials (en Inglés)

Formato

Libro Físico

Ilustrado por

Zoran Antonijevic

Robert A. Beckman

Editorial

CRC Press

Autor

Antonijevic, Zoran ; Beckman, Robert A.

Idioma

Inglés

N° páginas

322

Encuadernación

Tapa Dura

Dimensiones

23.9 x 16.3 x 2.3 cm

Peso

0.61 kg.

ISBN13

9781138052451

N° edición

Categorías

Investigación médica
Epidemiología y estadística médica
Farmacología
Probabilidad y estadística

Platform Trial Designs in Drug Development: Umbrella Trials and Basket Trials (en Inglés)

Zoran Antonijevic (Ilustrado por) · Robert A. Beckman (Ilustrado por) · CRC Press · Tapa Dura

Libro Nuevo

$ 111.590

$ 185.980

Ahorras: $ 74.390

40% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Miércoles 12 de Junio y el Miércoles 26 de Junio.

Lo recibirás en cualquier lugar de Chile entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Platform Trial Designs in Drug Development: Umbrella Trials and Basket Trials (en Inglés)"

Platform trials test multiple therapies in one indication, one therapy for multiple indications, or both. These novel clinical trial designs can dramatically increase the cost-effectiveness of drug development, leading to life-altering medicines for people suffering from serious illnesses, possibly at lower cost. Currently, the cost of drug development is unsustainable. Furthermore, there are particular problems in rare diseases and small biomarker defined subsets in oncology, where the required sample sizes for traditional clinical trial designs may not be feasible. The editors recruited the key innovators in this domain. The 20 articles discuss trial designs from perspectives as diverse as quantum computing, patient's rights to information, and international health. The book begins with an overview of platform trials from multiple perspectives. It then describes impacts of platform trials on the pharmaceutical industry's key stakeholders: patients, regulators, and payers. Next it provides advanced statistical methods that address multiple aspects of platform trials, before concluding with a pharmaceutical executive's perspective on platform trials. Except for the statistical methods section, only a basic qualitative knowledge of clinical trials is needed to appreciate the important concepts and novel ideas presented.